Human IGFBP5/IBP5 ORF/cDNA clone-Adenovirus plasmid (NM_000599.4)
Cat. No.: pGMAD001653
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IGFBP5/IBP5 adenoviral expression plasmid for IGFBP5 adenovirus packaging, IGFBP5 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
IGFBP5/IBP5 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAD001653 |
| Gene Name | IGFBP5 |
| Accession Number | NM_000599.4 |
| Gene ID | 3488 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 819 bp |
| Gene Alias | IBP5 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGGTGTTGCTCACCGCGGTCCTCCTGCTGCTGGCCGCCTATGCGGGGCCGGCCCAGAGCCTGGGCTCCTTCGTGCACTGCGAGCCCTGCGACGAGAAAGCCCTCTCCATGTGCCCCCCCAGCCCCCTGGGCTGCGAGCTGGTCAAGGAGCCGGGCTGCGGCTGCTGCATGACCTGCGCCCTGGCCGAGGGGCAGTCGTGCGGCGTCTACACCGAGCGCTGCGCCCAGGGGCTGCGCTGCCTCCCCCGGCAGGACGAGGAGAAGCCGCTGCACGCCCTGCTGCACGGCCGCGGGGTTTGCCTCAACGAAAAGAGCTACCGCGAGCAAGTCAAGATCGAGAGAGACTCCCGTGAGCACGAGGAGCCCACCACCTCTGAGATGGCCGAGGAGACCTACTCCCCCAAGATCTTCCGGCCCAAACACACCCGCATCTCCGAGCTGAAGGCTGAAGCAGTGAAGAAGGACCGCAGAAAGAAGCTGACCCAGTCCAAGTTTGTCGGGGGAGCCGAGAACACTGCCCACCCCCGGATCATCTCTGCACCTGAGATGAGACAGGAGTCTGAGCAGGGCCCCTGCCGCAGACACATGGAGGCTTCCCTGCAGGAGCTCAAAGCCAGCCCACGCATGGTGCCCCGTGCTGTGTACCTGCCCAATTGTGACCGCAAAGGATTCTACAAGAGAAAGCAGTGCAAACCTTCCCGTGGCCGCAAACGTGGCATCTGCTGGTGCGTGGACAAGTACGGGATGAAGCTGCCAGGCATGGAGTACGTTGACGGGGACTTTCAGTGCCACACCTTCGACAGCAGCAACGTTGAGTGA |
| ORF Protein Sequence | MVLLTAVLLLLAAYAGPAQSLGSFVHCEPCDEKALSMCPPSPLGCELVKEPGCGCCMTCALAEGQSCGVYTERCAQGLRCLPRQDEEKPLHALLHGRGVCLNEKSYREQVKIERDSREHEEPTTSEMAEETYSPKIFRPKHTRISELKAEAVKKDRRKKLTQSKFVGGAENTAHPRIISAPEMRQESEQGPCRRHMEASLQELKASPRMVPRAVYLPNCDRKGFYKRKQCKPSRGRKRGICWCVDKYGMKLPGMEYVDGDFQCHTFDSSNVE |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE0987-Ab | Anti-IBP5/ IGFBP5 functional antibody |
| Target Antigen | GM-Tg-g-SE0987-Ag | IGFBP5 protein |
| Cytokine | cks-Tg-g-GM-SE0987 | insulin-like growth factor binding protein 5 (IGFBP5) protein & antibody |
| ORF Viral Vector | pGMLP000569 | Human IGFBP5 Lentivirus plasmid |
| ORF Viral Vector | pGMAD001653 | Human IGFBP5 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000569 | Human IGFBP5 Lentivirus particle |
| ORF Viral Vector | vGMAD001653 | Human IGFBP5 Adenovirus particle |
Target information
| Target ID | GM-SE0987 |
| Target Name | IGFBP5 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3488 |
| Gene ID |
100034063 (Equus caballus), 101084305 (Felis catus), 16011 (Mus musculus), 25285 (Rattus norvegicus) 3488 (Homo sapiens), 404185 (Bos taurus), 610316 (Canis lupus familiaris), 696339 (Macaca mulatta) |
| Gene Symbols & Synonyms | IGFBP5,Igfbp5,IGFBP-5,IGFBP-5P,IGF-BP5,IBP5 |
| Target Alternative Names | IBP-5,IBP5,IGF-BP5,IGF-binding protein 5,IGFBP-5,IGFBP-5P,IGFBP5,Igfbp5,Insulin-like growth factor-binding protein 5 |
| Uniprot Accession |
P24593,P24594,Q05717,Q07079
Additional SwissProt Accessions: Q07079,P24594,P24593,Q05717 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | cancer, Breast Cancer, Dent disease |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000013425, ENSMUSG00000026185, ENSG00000115461, ENSBTAG00000059978, ENSCAFG00845024936, ENSMMUG00000041480 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


